Veracity Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Veracity Capital's GILD Position: Q2 2026 in Review
Veracity Capital increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $93.7K and bringing the position to 7,784 shares worth $983K. The position accounts for 0.27% of the portfolio, ranked #76.
Veracity Capital first reported a position in GILD in Q1 2020 and has held it in 14 quarters since. The position peaked at $986K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Veracity Capital held 7,784 shares of Gilead Sciences worth $983K as of Q2 2026.
- Veracity Capital bought 711 Gilead Sciences shares in Q2 2026, an estimated $93.7K.
- Gilead Sciences made up 0.27% of Veracity Capital's portfolio in Q2 2026, its #76 holding.
- Veracity Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 14 quarters since.
- Veracity Capital's Gilead Sciences position peaked at $986K in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.